Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAPERITONEALGeneric

INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER

CALCIUM CHLORIDE; DEXTROSE; SODIUM CHLORIDE; SODIUM LACTATE

Standard Dose
25.7MG/100ML;1.5GM/100ML;538MG/100ML;448MG/100ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER is listed in Drugs@FDA under application 019395 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CALCIUM CHLORIDE; DEXTROSE; SODIUM CHLORIDE; SODIUM LACTATE Form and strength SOLUTION;INTRAPERITONEAL - 25.7MG/100ML;1.5GM/100ML;538MG/100ML;448MG/100ML Sponsor FRESENIUS MEDCL Submission history Latest submission status date: 1999-09-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER is listed in Drugs@FDA under application 019395 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CALCIUM CHLORIDE; DEXTROSE; SODIUM CHLORIDE; SODIUM LACTATE Form and strength SOLUTION;INTRAPERITONEAL - 25.7MG/100ML;1.5GM/100ML;538MG/100ML;448MG/100ML Sponsor FRESENIUS MEDCL Submission history Latest submission status date: 1999-09-27 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; SODIUM CHLORIDE; SODIUM LACTATE) | Drug Monograph | MedicHelpline